PRALUENT
PRALUENT
Approved
DIN Number
02547732
Drug Class
Human
Market Date
Sep 16, 2024
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02547732
AIG Number0158030002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
C10AX14 ALIROCUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification24:06.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALIROCUMABActive
Strength: 300 MG / 2 ML
Monograph: ALIROCUMAB